Literature DB >> 24681733

The staining patterns of 53BP1 nuclear foci and 53BP1 mRNA level are associated with cervical cancer progression and metastasis.

Haiyan Zhu1, Hu Yan, Weiwei Jin, Chunxiu Dai, Zhiwen Chen, Feiyun Zheng, Xiangjuan Chen.   

Abstract

p53-binding protein 1 (53BP1) plays a key role in DNA damage response mechanism, which protects genome integrity and guards against cancer. Although abnormal DNA damage response type of 53BP1 nuclear foci (NF) have been indicated to be associated with many types of malignancies, how the staining pattern of 53BP1 NF and the mRNA level of 53BP1 correlate with the clinicopathologic characteristics of cervical cancer is still unclear. In this study, we examined the staining pattern and mRNA level of 53BP1 in cervical premalignant and malignant lesions and normal cervical tissue by immunofluorescence staining and quantitative real-time polymerase chain reaction. We found that the level of 53BP1 NF increased in the following order: normal cervical tissues, cervical intraepithelial neoplasia (CIN) 1, CIN2/3, and cervical cancers, indicating that the level of 53BP1 NF increases as cervical cancer initiates and progresses. In addition, we also found that abnormal DNA damage response type of 53BP1 NF and low mRNA level of 53BP1 was significantly correlated with high histologic grade of cervical cancer, and low mRNA level of 53BP1 was also significantly associated with positive lymph node metastasis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24681733     DOI: 10.1097/PGP.0000000000000079

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  Inhibition of FoxM1-Mediated DNA Repair by Imipramine Blue Suppresses Breast Cancer Growth and Metastasis.

Authors:  Subapriya Rajamanickam; Subbarayalu Panneerdoss; Aparna Gorthi; Santosh Timilsina; Benjamin Onyeagucha; Dmytro Kovalskyy; Dmitri Ivanov; Martha A Hanes; Ratna K Vadlamudi; Yidong Chen; Alexander J Bishop; Jack L Arbiser; Manjeet K Rao
Journal:  Clin Cancer Res       Date:  2016-02-29       Impact factor: 12.531

2.  Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma.

Authors:  Xi Zhang; Peng Huang; Liqiong Wang; Shu Chen; Basappa Basappa; Tao Zhu; Peter E Lobie; Vijay Pandey
Journal:  Cell Death Dis       Date:  2022-06-20       Impact factor: 9.685

Review 3.  Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy.

Authors:  Jun Zhao; Min Zhou; Chun Li
Journal:  Cancer Nanotechnol       Date:  2016-11-16

4.  Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16INK4a Expression.

Authors:  Sayaka Kawashita; Katsuya Matsuda; Hisayoshi Kondo; Yuriko Kitajima; Yuri Hasegawa; Takako Shimada; Michio Kitajima; Kiyonori Miura; Masahiro Nakashima; Hideaki Masuzaki
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

5.  LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1.

Authors:  Ping Luo; Shugui Wu; Kaibao Ji; Xia Yuan; Hongmi Li; Jinping Chen; Yunfei Tian; Yang Qiu; Xiaoming Zhong
Journal:  PLoS One       Date:  2020-11-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.